Artificial Intelligence in Drug Discovery Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

The Artificial Intelligence in Drug Discovery Market is segmented by Component Type (Software and Services), Application Type (Preclinical Testing, Drug Optimization, and Repurposing, Target Identification, Candidate Screening, De novo Drug Designing, and Others), Therapeutic Area (Oncology, Neurodegenerative Diseases, Cardiovascular Diseases, Metabolic Diseases, Rare Diseases, Infectious Diseases, and Genetic Diseases), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The report offers the value (in USD million) for the above segments.

Artificial Intelligence in Drug Discovery Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

AI in Drug Discovery Industry Overview

The artificial intelligence in the drug discovery market is moderately consolidated in nature due to the presence of a few companies operating globally as well as regionally. The competitive landscape includes an analysis of some international as well as local companies that hold market shares and are well known, including Microsoft, IBM, Exscientia, GNS Healthcare, Alphabet, Benevolent AI, Cloud, NVIDIA Corporation, DEEP GENOMICS, Neumora, Recursion, Notable, Insilico Medicine, and PathAI.

AI in Drug Discovery Market Leaders

  1. Microsoft

  2. IBM

  3. Exscientia

  4. GNS Healthcare

  5. Alphabet

  6. *Disclaimer: Major Players sorted in no particular order
Artificial Intelligence in Drug Discovery Market Concentration

Artificial Intelligence in Drug Discovery Report Snapshots

80% of our clients seek made-to-order reports. How do you want us to tailor yours?